SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-001602
Filing Date
2023-03-13
Accepted
2023-03-10 18:22:49
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_031023.htm   iXBRL 8-K 24360
  Complete submission text file 0001171843-23-001602.txt   196013

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20230310.xsd EX-101.SCH 3203
3 XBRL LABEL FILE crvs-20230310_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE crvs-20230310_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_031023_htm.xml XML 3610
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 23725155
SIC: 2834 Pharmaceutical Preparations